基本信息
浏览量:145
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
RESEARCH INTERESTS
Dr. Eric R Gamazon develops and applies genomic and computational methods to investigate the genetic architecture of complex traits, including disease risk and drug response, using functional genomics, machine learning, and phenomics. He is interested in what can be learned from DNA sequence and multi-omics data about disease mechanism, therapeutic intervention, molecular evolution, and biological function. An ongoing project involves understanding gene regulation across tissues and cell types to gain insights into disease mechanisms and therapeutic targets. He utilizes large-scale DNA biobank data linked to electronic health records, along with data science and computation, to identify genes involved in human health and disease, to discover novel biomarkers, and to enable a comprehensive systems view of the disease phenome.
His research develops approaches and methodologies that are broadly applicable, but these may be evaluated with specific disease areas, cell types, or genes. Overall goals are to understand the biology of genomes and to advance genomic medicine. He is part of the GTEx Consortium and the T2D-GENES Consortium. He was also a member of the International Warfarin Pharmacogenetics Consortium.
He is a recipient of the inaugural Genomic Innovator Award (2019) from the National Institutes of Health (NIH).
He is a faculty member in the Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center.
He is a Life Member (2019 -- present) of Clare Hall, University of Cambridge, able to return any time to participate in the intellectual life of the college. Clare Hall is a unique post-graduate college devoted to research and scholarship and a culturally rich and intellectually exciting academic community. In 2018, he was elected to a Clare Hall Visiting Fellowship to advance his research and scholarship. He was also a visiting scholar in the Department of Medicine, the MRC Epidemiology Unit, and the MRC Biostatistics Unit of the University of Cambridge.
研究兴趣
论文共 322 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
medRxiv : the preprint server for health sciences (2024)
Yu Chen,Sihan Liu,Zongyao Ren,Feiran Wang, Yi Jiang,Rujia Dai,Fangyuan Duan,Cong Han,Zhilin Ning,Yan Xia,Miao Li, Kai Yuan,
medRxiv : the preprint server for health sciences (2024)
Xavier Bledsoe,Eric R. Gamazon
The American Journal of Human Genetics (2024)
SCIENTIFIC REPORTSno. 1 (2024): 9991-9991
Marcus C.B. Tan, Chelsea A. Isom, Yangzi Liu,David-Alexandre Trégouët, Lang Wu,Dan Zhou,Eric R. Gamazon,Sara Lindstrom,Lu Wang, Erin Smith,William Gordon,Astrid Van Hylckama Vlieg,
EBioMedicine (2024): 105233
引用0浏览0引用
0
0
Nature genetics (2024)
Current protocolsno. 2 (2024): e981-e981
CELL REPORTS MEDICINEno. 2 (2024): 101430-101430
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn